1World Health Organization (2003) Diet, Nutrition and the Prevention of Chronic Diseases. Joint WHO/FAO Expert Consultation. WHO Technical Report Series no. 916. Geneva: WHO.
3World Cancer Research Fund & American Institute for Cancer Research (2007) Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington, DC: AICR.
4Duijnhoven, FJB, De Mesquita, HB, Ferrari, P, et al. (2009) Fruit, vegetables, and colorectal cancer risk: the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr 89, 1441–1452.
5Smith-Warner, SA, Genkinger, J & Giovannucci, E (2000) . In Nutritional Oncology, pp. 153–184 [Herber, D, Blackburn, GL and Go, VLM, editors]. San Diego: Academic Press Inc.
6Nichenametla, SN, Taruscio, TG, Barney, DL, et al. (2006) A review of the effects and mechanisms of polyphenolics in cancer. Crit Rev Food Sci Nutr 46, 161–183.
7Lambert, JD, Hong, J, Yang, G, et al. (2005) Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations. Am J Clin Nutr 81, Suppl., 284S–291S.
8Surh, YJ, Kundu, JK, Na, HK, et al. (2005) Redox sensitive transcription factors as prime targets for chemoprevention with anti-inflammatory and antioxidative phytochemicals. J Nutr 135, 2993S–3001S.
9Duthie, SJ, Johnson, W & Dobson, VL (1997) The effect of dietary flavonoids on DNA damage (strand breaks and oxidized pyrimidines) and growth in human cells. Mutat Res 390, 141–151.
10Sánchez de Medina, F, Vera, B, Gálvez, J, et al. (2002) Effect of quercitrin on the early stages of hapten induced colonic inflammation in the rat. Life Sci 70, 3097–3108.
11Kim, HP, Mani, I, Iversen, L, et al. (1998) Effects of naturally occurring flavonoids and biflavonoids on epidermal cyclooxygenase and lipoxygenase from guinea-pigs. Prostaglandins Leukot Essent Fatty Acids 58, 17–24.
12Kim, HP, Son, KH, Chang, HW, et al. (2004) Anti-inflammatory plant flavonoids and cellular action mechanisms. J Pharmacol Sci 96, 229–245.
13Peng, G, Dixon, DA, Muga, SJ, et al. (2006) Green tea polyphenol ( − )-epigallocatechin-3-gallate inhibits cyclooxygenase-2 expression in colon carcinogenesis. Mol Carcinog 45, 309–319.
14Daskiewicz, JB, Depeint, F, Viornery, L, et al. (2005) Effects of flavonoids on cell proliferation and caspase activation in a colonic cell line HT 29, SAR study. J Med Chem 48, 2790–2804.
15Franke, AA, Custer, LJ, Cooney, RV, et al. (2002) Inhibition of colonic aberrant crypt formation by the dietary flavonoids (+)-catechin and hesperidin. Adv Exp Med Biol 505, 123–133.
16Gosse, F, Guyot, S, Roussi, S, et al. (2005) Chemopreventive properties of apple procyanidins on human colon cancer derived metastatic SW620 cells and in a rat model of colon carcinogenesis. Carcingogenesis 26, 1291–1295.
17Williams, RJ, Spencer, JPE & Rice-Evans, C (2004) Flavonoids: antioxidants or signalling molecules? Free Rad Biol Med 36, 838–849.
18Van Dross, R, Xue, Y, Knudson, A, et al. (2003) The chemopreventive bioflavonoid apigenin modulates signal transduction pathways in keratinocyte and colon carcinoma cell lines. J Nutr 133, 3800S–3804S.
19Halliwell, B, Zhao, KC & Whiteman, M (2000) The gastrointestinal tract: a major site of antioxidant action? Free Radic Res 33, 819–830.
20Lin, J, Zhang, SM, Wu, K, et al. (2006) Flavonoid intake and colorectal cancer risk in men and women. Am J Epidemiol 164, 644–651.
21Hirvonen, T, Virtamo, J, Korhonen, P, et al. (2001) Flavonol and flavone intake and the risk of cancer in male smokers (Finland). Cancer Causes Control 12, 789–796.
22Knekt, P, Jarvinen, R, Seppanen, R, et al. (1997) Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epidemiol 146, 223–230.
23Knekt, P, Kumpulainen, J, Järvinen, R, et al. (2002) Flavonoid intake and risk of chronic disease. Am J Clin Nutr 76, 560–568.
24Arts, ICW, Hollman, PCH, de Mesquita, HBB, et al. (2001) Dietary catechins and epithelial cancer incidence: the Zutphen elderly study. Int J Cancer 92, 298–302.
25Arts, ICW, Jacobs, DR Jr, Gross, M, et al. (2002) Dietary catechins and cancer incidence among postmenopausal women: the Iowa Women's Health Study (United States). Cancer Causes Control 13, 373–382.
26Kyle, JAM & Duthie, GG (2006) . In Flavonoids; Chemistry, Biochemistry and Health Implications, pp. 219–263 [Andersen, OM and Markham, K, editors]. New York: Taylor and Francis Group.
27Hertog, MGL, Hollman, PCH & Katan, MB (1992) Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in The Netherlands. J Agric Food Chem 40, 2379–2783.
28Rossi, M, Negri, E, Talamini, R, et al. (2006) Flavonoids and colorectal cancer in Italy. Cancer Epidemiol Biomarkers Prev 15, 1555–1558.
29Theodoratou, E, Kyle, J, Cetnarskyj, R, et al. (2007) Dietary flavonoids and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 16, 684–693.
30Scottish Health Service Advisory Council (1993) The Scottish Diet: Report of a Working Party to the Chief Medical Officer for Scotland. Edinburgh: Scottish Office Home and Health Department.
31McKie, L, MacInnes, A, Hendry, J, et al. (2000) The food consumption patterns and perceptions of dietary advice of older people. J Hum Nutr Diet 13, 173–183.
32Turrini, A, Saba, A, Perrone, D, et al. (2001) Food consumption patterns in Italy: the INN-CA study 1994–1996. Eur J Clin Nutr 55, 571–588.
33Little, J, Sharp, L, Masson, LF, et al. (2006) Colorectal cancer and genetic polymorphisms of CYP1A1, GSTM1 and GSTT1: a case–control study in the Grampian region of Scotland. Int J Cancer 119, 2155–2164.
34Food Standards Agency (2002) McCance and Widdowson's The Composition of Foods, 6th summary ed.Cambridge, UK: Royal Society of Chemistry.
35Kyle, J, Masson, L, Duthie, GG, et al. (2002) Estimating dietary flavonoid intake: comparison of a semi-quantitative food frequency questionnaire with 4-day weighed diet records in a Scottish population. Proc Nutr Soc 61, 69A.
36Masson, LF, McNeill, G, Tomany, JO, et al. (2003) Statistical approaches for assessing the relative validity of a food frequency questionnaire: use of correlation coefficients and the κ statistic. Public Health Nutr 6, 313–321.
37Willett, W (1998) . In Nutritional Epidemiology, 2nd ed., pp. 288–291 [Willett, W, editor]. New York: Oxford University Press.
38Macfarlane, TV, Gray, RJM, Kincey, J, et al. (2007) Factors associated with the temporomandibular disorder, pain dysfunction syndrome (PDS): Manchester case–control study. Oral Dis 7, 321–330.
39Department for Environment, Food and Rural Affairs (2007) Family Food – Report on the Expenditure of Food Survey. National Statistics Publication. London: The Stationery Office.
40United States Department of Agriculture (2003) USDA Database for the Flavonoid Content of Selected Foods. Beltsville, MD: USDA.
41Hertog, MGL, Hollman, PCH & van de Putte, B (1993) Content of potentially anticarcinogenic flavonoids of tea infusions, wines and fruit juices. J Agric Food Chem 41, 1242–1246.
42Arts, IC, van de Putte, B & Hollman, PC (2000) Catechin contents of foods commonly consumed in The Netherlands. 1. Fruits, vegetables, staple foods, and processed foods. J Agric Food Chem 8, 1746–1751.
43Arts, IC, van De Putte, B & Hollman, PC (2000) Catechin contents of foods commonly consumed in The Netherlands. 2. Tea, wine, fruit juices, and chocolate milk. J Agric Food Chem 48, 1752–1757.
44Kyle, JAM (2003) .
45Hollman, PCH & Arts, ICW (2000) Flavonols, flavones and flavanols – nature, occurrence and dietary burden. J Sci Food Agric 80, 1081–1093.
46Duthie, GG, Duthie, SJ & Kyle, JAM (2000) Plant polyphenols in cancer and heart disease: implications as nutritional antioxidants. Nutr Res Rev 13, 79–106.
47Heim, KE, Tagliaferro, AR & Bobilya, DJ (2002) Flavonoid antioxidants: chemistry, metabolism and structure–activity relationships. J Nutr Biochem 13, 572–584.
48Agullo, G, Gamet, L, Besson, C, et al. (1994) Quercetin exerts a preferential cytotoxic effect on active dividing colon carcinoma HT29 & Caco-2 cells. Cancer Lett 87, 55–63.
49Kim, WK, Bang, MH, Kim, ES, et al. (2005) Quercetin decreases the expression of ErbB2 and ErbB3 proteins in HT-29 human colon cancer cells. J Nutr Biochem 16, 155–162.
50Park, CH, Chang, JY, Hahm, ER, et al. (2005) Quercetin, a potent inhibitor against β-catenin/Tcf signalling in SW480 colon cancer cells. Biochem Biophys Res Commun 328, 227–234.
51Mouat, MF, Kolli, K, Orlando, R, et al. (2005) The effects of quercetin on SW480 human colon carcinoma cells: a proteomic study. Nutr J 4, 11.
52Wenzel, U, Hertzog, A, Kuntz, S, et al. (2004) Protein expression profiling identifies molecular targets of quercetin as a major dietary flavonoid in human colon cancer cells. Proteomics 4, 2160–2174.
53Dubé, C, Rostom, A, Lewin, G, et al. (2007) The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med 146, 365–375.
54Vane, JR & Botting, RM (1998) Anti-inflammatory drugs and their mechanism of action. Inflamm Res 47, S78–S87.